CAT# | CPM-1-0453 |
Sequence | SLYNTVATL |
Size | 50 Test, 100 Test | Antigen | Virus LCMV | Epitope Origin | HIV gag | MHC Restriction | HLA-A_02_01 | Conjugate | BV421 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0768 | HLA-A_02_01 Neg ALI tetramer-ALIAPVHAV-PE labeled | Inquiry | ||
CPM-1-0205 | HLA-A_01_01 RSV M229-237 tetramer-YLEKESIYY-PE labeled | Inquiry | ||
CPM-1-0638 | HLA-A_02_01 gp100 (wild) tetramer-ITDQVPFSV-APC labeled | Inquiry | ||
CPM-1-0583 | HLA-A_01_01 RSV M229-237 tetramer-YLEKESIYY-APC labeled | Inquiry | ||
CPM-1-0105 | H-2Ld β-galactosidase tetramer-TPHPARIGL-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
ICl 154,129 is a new compound that shows selectivity as an antagonist of [Leu5]enkephalin and [D-AIa2, D-Leu5]en ...
Trimetazidine is a partial fatty acid oxidation inhibitor that inhibits 3-ketoacyl CoA thiolase, one of the enzymes of fatty ...
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
The voltage-gated Kv1.3 channel in effector memory T cells serves as a new therapeutic target for multiple scler ...